Anti-c-Myb antibody [EPR718(2)]
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(11 Publications)
Rabbit Recombinant Monoclonal c-Myb antibody. Suitable for WB and reacts with Human samples. Cited in 11 publications.
View Alternative Names
Transcriptional activator Myb, Proto-oncogene c-Myb, MYB
- WB
Lab
Western blot - Anti-c-Myb antibody [EPR718(2)] (AB109127)
Lane 1 : Wild-type HAP1 whole cell lysate (20 μg)
Lane 2 : c-Myb knockout HAP1 whole cell lysate (20 μg)
Lanes 1 - 2 : Merged signal (red and green). Green - ab109127 observed at 75 kDa. Red - loading control, ab9484, observed at 37 kDa.
ab109127 was shown to specifically react with c-Myb in wild-type HAP1 cells as signal was lost in c-Myb knockout cells. Wild-type and c-Myb knockout samples were subjected to SDS-PAGE. ab109127 and ab9484 (Mouse anti-GAPDH loading control) were incubated overnight at 4°C at 1/1000 dilution and 1/20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/10000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-c-Myb antibody [EPR718(2)] (ab109127)
Predicted band size: 72 kDa
false
- WB
Unknown
Western blot - Anti-c-Myb antibody [EPR718(2)] (AB109127)
All lanes:
Western blot - Anti-c-Myb antibody [EPR718(2)] (ab109127) at 1/1000 dilution
Lane 1:
Jurkat cell lysates at 10 µg
Lane 2:
MOLT4 cell lysates at 10 µg
Predicted band size: 72 kDa
false
Related conjugates and formulations (1)
-
Anti-c-Myb antibody [EPR718(2)] - BSA and Azide free
Reactivity data
Product details
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The protein serves as a master regulator in the development of various cell types. It is not part of a traditional complex but interacts with other proteins to exert its function such as binding with co-activators or repressors to modulate gene expression. c-Myb controls the transcription of genes that are critical for cell cycle regulation and differentiation especially in the context of blood cell lineages. The protein is particularly influential in the production of red blood cells and white blood cells.
Pathways
C-Myb fits integrally into known hematopoietic signaling cascades and the Wnt signaling pathway. It works alongside other proteins like cyclin-dependent kinase (CDK) family members and transcription factor GATA-1 to modulate lineage-specific gene expression. Through its regulatory actions c-Myb influences the activation of downstream effectors that propagate signals essential for maintaining cellular functions within these pathways. The modulation of these pathways underlines its role in cell fate decisions.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (11)
Recent publications for all applications. Explore the full list and refine your search
Blood 139:1659-1669 PubMed35007327
2022
Applications
Unspecified application
Species
Unspecified reactive species
British journal of cancer 126:1205-1214 PubMed34837075
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 11:761693 PubMed34868977
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 11:832 PubMed33028809
2020
Applications
Unspecified application
Species
Unspecified reactive species
Blood cells, molecules & diseases 69:1-9 PubMed29227829
2017
Applications
Unspecified application
Species
Unspecified reactive species
Leukemia 32:882-889 PubMed29089643
2017
Applications
Unspecified application
Species
Unspecified reactive species
Oncotarget 8:30138-30150 PubMed28404913
2017
Applications
Unspecified application
Species
Unspecified reactive species
Science signaling 7:ra47 PubMed24847116
2014
Applications
Unspecified application
Species
Unspecified reactive species
Oncogene 34:436-44 PubMed24469049
2014
Applications
Unspecified application
Species
Unspecified reactive species
Blood cells, molecules & diseases 52:68-75 PubMed23910958
2013
Applications
IHC
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com